Crystal structures of human 108V and 108M catechol O-methyltransferase.
暂无分享,去创建一个
W. W. Parson | K. Rutherford | R. Stenkamp | I. L. Trong | I. Le Trong | W W Parson | I Le Trong | R E Stenkamp | K Rutherford
[1] Xiaodong Cheng,et al. Structural basis of allele variation of human thiopurine‐S‐methyltransferase , 2007, Proteins.
[2] E. Weiderpass,et al. Catechol-O-methyltransferase gene polymorphism and post-menopausal breast cancer risk. , 2003, Carcinogenesis.
[3] A. Jalanko,et al. Structure of the rat catechol-O-methyltransferase gene: separate promoters are used to produce mRNAs for soluble and membrane-bound forms of the enzyme. , 1993, DNA and cell biology.
[4] Jina Yu,et al. Biochemical and molecular modeling studies of the O-methylation of various endogenous and exogenous catechol substrates catalyzed by recombinant human soluble and membrane-bound catechol-O-methyltransferases. , 2007, Chemical research in toxicology.
[5] Jack Snoeyink,et al. Nucleic Acids Research Advance Access published April 22, 2007 MolProbity: all-atom contacts and structure validation for proteins and nucleic acids , 2007 .
[6] R. Weinshilboum,et al. Human thiopurine S-methyltransferase pharmacogenetics: variant allozyme misfolding and aggresome formation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[7] J. Yager,et al. Functional and structural comparisons of cysteine residues in the Val108 wild type and Met108 variant of human soluble catechol O-methyltransferase. , 2005, Chemico-biological interactions.
[8] V. Daggett,et al. The 108M polymorph of human catechol O-methyltransferase is prone to deformation at physiological temperatures. , 2006, Biochemistry.
[9] Kenneth K Kidd,et al. Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles , 1999, Biological Psychiatry.
[10] R. Weinshilboum,et al. Pharmacogenetics of N‐methylation: Heritability of human erythrocyte histamine N‐methyltransferase activity , 1988, Clinical pharmacology and therapeutics.
[11] R. Weinshilboum,et al. Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase. , 1999, Annual review of pharmacology and toxicology.
[12] V. Daggett,et al. The histamine N-methyltransferase T105I polymorphism affects active site structure and dynamics. , 2008, Biochemistry.
[13] R. Weinshilboum,et al. Thermal stability and the biochemical genetics of erythrocyte catechol‐O‐methyltransferase and plasma dopamine‐β‐hydroxylase , 1981, Clinical genetics.
[14] D. Noh,et al. Relationship between the Val158Met polymorphism of catechol O-methyl transferase and breast cancer. , 2001, Pharmacogenetics.
[15] R. Weinshilboum,et al. Electrophoretic analysis of low and high activity forms of catechol-O-methyltransferase in human erythrocytes. , 1992, Life sciences.
[16] M. Karvonen,et al. Suicidal behavior in patients with schizophrenia is related to COMT polymorphism , 2000, Psychiatric genetics.
[17] Abraham Weizman,et al. COMT: A common susceptibility gene in bipolar disorder and schizophrenia , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[18] I. Ulmanen,et al. Molecular mechanisms controlling the rate and specificity of catechol O-methylation by human soluble catechol O-methyltransferase. , 2001, Molecular pharmacology.
[19] J. Axelrod,et al. Enzymatic O-methylation of epinephrine and other catechols. , 1958, The Journal of biological chemistry.
[20] R. Coppola,et al. Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia. , 2003, Archives of general psychiatry.
[21] T. N. Bhat,et al. The Protein Data Bank , 2000, Nucleic Acids Res..
[22] B. Stoddard,et al. Oxidative Inhibition of Human Soluble Catechol-O-methyltransferase* , 2004, Journal of Biological Chemistry.
[23] M. Owen,et al. Is COMT a susceptibility gene for schizophrenia? , 2007, Schizophrenia bulletin.
[24] C. Karrer,et al. Mass spectrometric analysis of human soluble catechol O-methyltransferase expressed in Escherichia coli. Identification of a product of ribosomal frameshifting and of reactive cysteines involved in S-adenosyl-L-methionine binding. , 1994, European journal of biochemistry.
[25] R. Weinshilboum,et al. Genetics of red cell COMT activity: analysis of thermal stability and family data. , 1981, American journal of medical genetics.
[26] J. Ott,et al. Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorder. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[27] M. A. Carrondo,et al. Comparative Study of ortho- and meta-Nitrated Inhibitors of Catechol-O-methyltransferase: Interactions with the Active Site and Regioselectivity of O-Methylation , 2006, Molecular Pharmacology.
[28] D E McRee,et al. XtalView/Xfit--A versatile program for manipulating atomic coordinates and electron density. , 1999, Journal of structural biology.
[29] P. Soares-da-Silva,et al. Molecular modeling and metabolic studies of the interaction of catechol-O-methyltransferase and a new nitrocatechol inhibitor. , 2003, Drug metabolism and disposition: the biological fate of chemicals.
[30] K. Nolan,et al. Aggressive behavior in schizophrenia is associated with the low enzyme activity COMT polymorphism: A replication study , 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[31] F. Diederich,et al. X-ray Crystal Structure of a Bisubstrate Inhibitor Bound to the Enzyme Catechol-O-methyltransferase: A Dramatic Effect of Inhibitor Preorganization on Binding Affinity. , 2001, Angewandte Chemie.
[32] J. Yager,et al. Equine catechol estrogen 4-hydroxyequilenin is a more potent inhibitor of the variant form of catechol-O-methyltransferase. , 2004, Chemical research in toxicology.
[33] J. Yager,et al. Characterization of human soluble high and low activity catechol-O-methyltransferase catalyzed catechol estrogen methylation. , 2002, Pharmacogenetics.
[34] Anders Liljas,et al. Crystal structure of catechol O-methyltransferase , 1994, Nature.
[35] V. Daggett,et al. The V108M mutation decreases the structural stability of catechol O-methyltransferase. , 2008, Biochimica et biophysica acta.
[36] Jennifer L. Martin,et al. SAM (dependent) I AM: the S-adenosylmethionine-dependent methyltransferase fold. , 2002, Current opinion in structural biology.
[37] Axel T. Brunger,et al. Assessment of Phase Accuracy by Cross Validation: the Free R Value. Methods and Applications , 1993 .
[38] R. Nussbaum,et al. Midbrain dopamine and prefrontal function in humans: interaction and modulation by COMT genotype , 2005, Nature Neuroscience.
[39] J. Yager,et al. Catechol estrogen 4-hydroxyequilenin is a substrate and an inhibitor of catechol-O-methyltransferase. , 2003, Chemical research in toxicology.
[40] M. Egan,et al. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. , 2004, American journal of human genetics.
[41] A. Labbé,et al. Isolated familial adrenocorticotropin deficiency: prenatal diagnosis by maternal plasma estriol assay. , 1988, American journal of medical genetics.
[42] Conrad C. Huang,et al. UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..
[43] P. Männistö,et al. Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. , 1999, Pharmacological reviews.
[44] J. Tenhunen,et al. Cloning, expression and structure of catechol-O-methyltransferase. , 1995, Biochimica et biophysica acta.
[45] P. Scambler. The 22q11 deletion syndromes. , 2000, Human molecular genetics.
[46] M. Harding,et al. Small revisions to predicted distances around metal sites in proteins. , 2006, Acta crystallographica. Section D, Biological crystallography.
[47] R. Weinshilboum,et al. Inheritance of low erythrocyte catechol-o-methyltransferase activity in man. , 1977, American journal of human genetics.
[48] Tommi H. Nyrönen,et al. A structure-activity relationship study of catechol-O-methyltransferase inhibitors combining molecular docking and 3D QSAR methods , 2003, J. Comput. Aided Mol. Des..
[49] Michael C O'Donovan,et al. A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain. , 2003, American journal of human genetics.
[50] A. Vagin,et al. MOLREP: an Automated Program for Molecular Replacement , 1997 .
[51] T. Kiviluoto,et al. Genomic organization of the human catechol O-methyltransferase gene and its expression from two distinct promoters. , 1994, European Journal of Biochemistry.
[52] P. Soares-da-Silva,et al. Synthesis, biological evaluation, and molecular modeling studies of a novel, peripherally selective inhibitor of catechol-O-methyltransferase. , 2004, Journal of medicinal chemistry.
[53] F. Diederich,et al. Bisubstrate inhibitors for the enzyme catechol-O-methyltransferase (COMT): influence of inhibitor preorganisation and linker length between the two substrate moieties on binding affinity. , 2003, Organic & biomolecular chemistry.
[54] A. Darvasi,et al. Further tests of the association between schizophrenia and single nucleotide polymorphism markers at the catechol-O-methyltransferase locus in an Askenazi Jewish population using microsatellite markers , 2005, Psychiatric genetics.
[55] J Volavka,et al. Association between catechol O-methyltransferase genotype and violence in schizophrenia and schizoaffective disorder. , 1998, The American journal of psychiatry.
[56] Marjorie M. Harding,et al. Metal-ligand geometry relevant to proteins and in proteins: sodium and potassium. , 2002, Acta crystallographica. Section D, Biological crystallography.
[57] Xiaodong Cheng,et al. Structural basis for inhibition of histamine N-methyltransferase by diverse drugs. , 2005, Journal of molecular biology.
[58] R. Weinshilboum,et al. Catechol-O-methyltransferase: thermolabile enzyme in erythrocytes of subjects homozygous for allele for low activity. , 1979, Science.
[59] M. A. Carrondo,et al. Kinetics and crystal structure of catechol-o-methyltransferase complex with co-substrate and a novel inhibitor with potential therapeutic application. , 2002, Molecular pharmacology.
[60] Z Dembic,et al. Human catechol-O-methyltransferase: cloning and expression of the membrane-associated form. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[61] J. Volavka,et al. Analysis of a functional catechol-O-methyltransferase gene polymorphism in schizophrenia: evidence for association with aggressive and antisocial behavior , 1997, Psychiatry Research.
[62] R Kucherlapati,et al. Association of codon 108/158 catechol-O-methyltransferase gene polymorphism with the psychiatric manifestations of velo-cardio-facial syndrome. , 1996, American journal of medical genetics.
[63] S. Aksoy,et al. Catechol O-methyltransferase pharmacogenetics: photoaffinity labelling and western blot analysis of human liver samples. , 1993, Pharmacogenetics.
[64] E A Merritt,et al. Raster3D: photorealistic molecular graphics. , 1997, Methods in enzymology.
[65] W. W. Parson,et al. Catecholamines in patients with 22q11.2 deletion syndrome and the low-activity COMT polymorphism , 2001, Neurology.
[66] Z. Otwinowski,et al. [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.
[67] R J Roberts,et al. AdoMet-dependent methylation, DNA methyltransferases and base flipping. , 2001, Nucleic acids research.
[68] M. Nishibori,et al. Two polymorphic forms of human histamine methyltransferase: structural, thermal, and kinetic comparisons. , 2001, Structure.
[69] Jurg Ott,et al. Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive-compulsive disorder , 1999, Biological Psychiatry.
[71] W. Evans,et al. Enhanced proteolysis of thiopurine S-methyltransferase (TPMT) encoded by mutant alleles in humans (TPMT*3A, TPMT*2): mechanisms for the genetic polymorphism of TPMT activity. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[72] R. Weinshilboum,et al. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. , 1996, Pharmacogenetics.
[73] Joshua A. Bueller,et al. COMT val158met Genotype Affects µ-Opioid Neurotransmitter Responses to a Pain Stressor , 2003, Science.
[74] I. Ulmanen,et al. Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. , 1995, Biochemistry.
[75] P. Kraulis. A program to produce both detailed and schematic plots of protein structures , 1991 .
[76] W. Maixner,et al. Genetic basis for individual variations in pain perception and the development of a chronic pain condition. , 2005, Human molecular genetics.
[77] J. Beckmann,et al. A highly significant association between a COMT haplotype and schizophrenia. , 2002, American journal of human genetics.
[78] J. Yager,et al. Catechol-O-methyltransferase low activity genotype (COMTLL) is associated with low levels of COMT protein in human hepatocytes. , 2004, Cancer letters.
[79] R. Weinshilboum,et al. Human liver catechol‐O‐methyltransferase pharmacogenetics , 1990, Clinical pharmacology and therapeutics.
[80] R. Weinshilboum,et al. Human catechol O-methyltransferase genetic variation: gene resequencing and functional characterization of variant allozymes , 2004, Molecular Psychiatry.
[81] N. Roodi,et al. Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms. , 2001, Cancer research.
[82] A. Friedhoff,et al. Multiple molecular forms of catechol-O-methyltransferase. Evidence for two distinct forms, and their purification and physical characterization. , 1979, Journal of Biological Chemistry.
[83] F. Diederich,et al. Structure-based design, synthesis, and in vitro evaluation of bisubstrate inhibitors for catechol O-methyltransferase (COMT). , 2000, Chemistry.
[84] G. Murshudov,et al. Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.
[85] S. Kaakkola,et al. General properties and clinical possibilities of new selective inhibitors of catechol O-methyltransferase. , 1994, General pharmacology.